Actemra

ACTEMRA is a prescription medicine used:

• To treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease modifying antirheumatic drug (DMARD) has been used and did not work well

• To treat adults with giant cell arteritis (GCA)

• To treat people with active polyarticular juvenile idiopathic arthritis (PJIA) 2 years of age and older

• To treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older

• For slowing the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD) (also known as scleroderma-associated ILD).

It is not known if ACTEMRA is safe and effective in children with PJIA or SJIA under 2 years of age or in children with conditions other than PJIA or SJIA.